Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000558922 | SCV000644484 | likely benign | Tuberous sclerosis 2 | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000561917 | SCV000675652 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001584295 | SCV001818332 | likely benign | not provided | 2018-11-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000558922 | SCV002039392 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000561917 | SCV002533468 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-01 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002497150 | SCV002811277 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-09-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999301 | SCV004818749 | likely benign | Tuberous sclerosis syndrome | 2023-03-23 | criteria provided, single submitter | clinical testing |